Kristin C. Pothier

Kristin Ciriello Pothier is the KPMG U.S. National Life Sciences Sector Leader, as well as the Global and National Healthcare and Life Sciences (HCLS) Deal Advisory & Strategy Leader. With over 25 years in strategy consulting and scientific and clinical research in the healthcare and life sciences industries; her areas of focus are commercial strategy, growth strategy, and M&A for pharmaceutical; diagnostics, device, and consumer health companies; investors; and medical institutions worldwide. She is a leader in precision medicine and in clinical diagnostics laboratory innovation, developing product and service strategies and operations with on-the-ground experience in the Americas, Europe, Asia, India, and the Middle East. Her book, Personalizing Precision Medicine, has garnered attention worldwide for its all-inclusive and comprehensive look at global precision medicine.

Kristin also works with health systems and affiliated organizations on their innovative services strategies, diligences, and operations, including clinical trial program development, clinical laboratory builds, health IT, hospital services, and clinical outreach strategy.

Earlier in her career, Kristin was a partner and the global head of Life Sciences Strategy at EY-Parthenon and a partner at Health Advances, where she built those businesses from single deals–focused offices to global organizations. She started her career as a geneticist and clinical diagnostics developer at Genome Therapeutics and Genzyme/Sanofi.

Kristin holds an MS in Clinical Epidemiology, Health Management, and Maternal and Child Health from the Harvard School of Public Health and a BA in Biochemistry from Smith College. She and her husband Bryan live in Boston with their lively teens Liv and Luke.